Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciana Scalone

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Pharmacological Research|January 13, 2006
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCAFrancesca Rossetti, Simona De Portu, Enrica Menditto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Italian population-based values of EQ-5D health statesLuciana Scalone, Paolo A Cortesi, Roberta Ciampichini, et al.
Internal and Emergency Medicine|August 29, 2012
Patient preferences and willingness to pay for different options of anticoagulant therapyMarco Moia, Lorenzo Giovanni Mantovani, Monica Carpenedo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 28, 2012
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyM F Janssen, A Simon Pickard, Dominik Golicki, et al.
Clinical and Experimental Rheumatology|October 18, 2012
The rationale of pharmacoeconomic analysis in rheumatologic indicationsGiuseppe Turchetti, Luciana Scalone, Ornella Della Casa Alberighi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2009
Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patientsLuciana Scalone, Francesca Borghetti, Giuliano Brunori, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 30, 2012
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseasesLuciana Scalone, Roberta Ciampichini, Stefano Fagiuoli, et al.
Plos One|December 4, 2014
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databasesLuciana Scalone, Giancarlo Cesana, Gianluca Furneri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value setsBen van Hout, M F Janssen, You-Shan Feng, et al.
Patient Preference and Adherence|November 10, 2018
Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseasesLuciana Scalone, Piercarlo Sarzi-Puttini, Luigi Sinigaglia, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Pharmacological Research|January 13, 2006
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCAFrancesca Rossetti, Simona De Portu, Enrica Menditto, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013
Italian population-based values of EQ-5D health statesLuciana Scalone, Paolo A Cortesi, Roberta Ciampichini, et al.
Internal and Emergency Medicine|August 29, 2012
Patient preferences and willingness to pay for different options of anticoagulant therapyMarco Moia, Lorenzo Giovanni Mantovani, Monica Carpenedo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 28, 2012
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country studyM F Janssen, A Simon Pickard, Dominik Golicki, et al.
Clinical and Experimental Rheumatology|October 18, 2012
The rationale of pharmacoeconomic analysis in rheumatologic indicationsGiuseppe Turchetti, Luciana Scalone, Ornella Della Casa Alberighi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2009
Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patientsLuciana Scalone, Francesca Borghetti, Giuliano Brunori, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 30, 2012
Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseasesLuciana Scalone, Roberta Ciampichini, Stefano Fagiuoli, et al.
Plos One|December 4, 2014
Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databasesLuciana Scalone, Giancarlo Cesana, Gianluca Furneri, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2012
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value setsBen van Hout, M F Janssen, You-Shan Feng, et al.
Patient Preference and Adherence|November 10, 2018
Patients', physicians', nurses', and pharmacists' preferences on the characteristics of biologic agents used in the treatment of rheumatic diseasesLuciana Scalone, Piercarlo Sarzi-Puttini, Luigi Sinigaglia, et al.
Pageof 4